Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Beta(2)-microglobulin as a negative growth regulator of myeloma cells.

Min R, Li Z, Epstein J, Barlogie B, Yi Q.

Br J Haematol. 2002 Aug;118(2):495-505.

PMID:
12139738
2.

Myeloma cells express Fas antigen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis.

Shima Y, Nishimoto N, Ogata A, Fujii Y, Yoshizaki K, Kishimoto T.

Blood. 1995 Feb 1;85(3):757-64.

3.

Interleukin-21 is a growth and survival factor for human myeloma cells.

Brenne AT, Ro TB, Waage A, Sundan A, Borset M, Hjorth-Hansen H.

Blood. 2002 May 15;99(10):3756-62.

4.

Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells.

Taetle R, Dos Santos B, Akamatsu K, Koishihara Y, Ohsugi Y.

Clin Cancer Res. 1996 Feb;2(2):253-9.

5.
6.

Beta(2)-microglobulin identified as an apoptosis-inducing factor and its characterization.

Mori M, Terui Y, Ikeda M, Tomizuka H, Uwai M, Kasahara T, Kubota N, Itoh T, Mishima Y, Douzono-Tanaka M, Yamada M, Shimamura S, Kikuchi J, Furukawa Y, Ishizaka Y, Ikeda K, Mano H, Ozawa K, Hatake K.

Blood. 1999 Oct 15;94(8):2744-53.

7.

Selective cyclooxygenase 2 inhibitor NS-398 induces apoptosis in myeloma cells via a Bcl-2 independent pathway.

Zhang M, Abe Y, Matsushima T, Nishimura J, Nawata H, Muta K.

Leuk Lymphoma. 2005 Mar;46(3):425-33.

PMID:
15621834
8.
9.

Interleukin-6 sensitizes multiple myeloma cell lines for apoptosis induced by interferon-alpha.

Minami R, Muta K, Ilseung C, Abe Y, Nishimura J, Nawata H.

Exp Hematol. 2000 Mar;28(3):244-55.

PMID:
10720689
11.

FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance.

Yasui H, Hideshima T, Raje N, Roccaro AM, Shiraishi N, Kumar S, Hamasaki M, Ishitsuka K, Tai YT, Podar K, Catley L, Mitsiades CS, Richardson PG, Albert R, Brinkmann V, Chauhan D, Anderson KC.

Cancer Res. 2005 Aug 15;65(16):7478-84.

12.

Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors, a novel class of agents, in multiple myeloma.

Hideshima T, Chauhan D, Hayashi T, Podar K, Akiyama M, Mitsiades C, MItsiades N, Gong B, Bonham L, de Vries P, Munshi N, Richardson PG, Singer JW, Anderson KC.

Cancer Res. 2003 Dec 1;63(23):8428-36.

13.
15.

MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo.

Hideshima T, Neri P, Tassone P, Yasui H, Ishitsuka K, Raje N, Chauhan D, Podar K, Mitsiades C, Dang L, Munshi N, Richardson P, Schenkein D, Anderson KC.

Clin Cancer Res. 2006 Oct 1;12(19):5887-94.

16.

Proteasome inhibitors induce growth inhibition and apoptosis in myeloma cell lines and in human bone marrow myeloma cells irrespective of chromosome 13 deletion.

Zavrski I, Naujokat C, Niemöller K, Jakob C, Heider U, Langelotz C, Fleissner C, Eucker J, Possinger K, Sezer O.

J Cancer Res Clin Oncol. 2003 Jul;129(7):383-91. Epub 2003 Jul 8.

PMID:
12851815
17.

All-trans retinoic acid can intensify the growth inhibition and differentiation induction effect of rosiglitazone on multiple myeloma cells.

Huang H, Wu D, Fu J, Chen G, Chang W, Chow HC, Leung AY, Liang R.

Eur J Haematol. 2009 Sep;83(3):191-202. doi: 10.1111/j.1600-0609.2009.01277.x. Epub 2009 May 8.

PMID:
19467017
19.

RIP kinase is involved in arsenic-induced apoptosis in multiple myeloma cells.

Bajenova O, Tang B, Pearse R, Feinman R, Childs BH, Michaeli J.

Apoptosis. 2004 Sep;9(5):561-71.

PMID:
15314284
20.

Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.

Ganten TM, Haas TL, Sykora J, Stahl H, Sprick MR, Fas SC, Krueger A, Weigand MA, Grosse-Wilde A, Stremmel W, Krammer PH, Walczak H.

Cell Death Differ. 2004 Jul;11 Suppl 1:S86-96.

Items per page

Supplemental Content

Write to the Help Desk